Cancer Epidemiol Biomarkers Prev

• 

  Publication Venue For

  • Novel Variants of ELP2 and PIAS1 in the Interferon Gamma Signaling Pathway Are Associated with Non-Small Cell Lung Cancer Survival. 2020
  • APOB Genotypes and CDH13 Haplotypes in the Cholesterol-Related Pathway Genes Predict Non-Small Cell Lung Cancer Survival..  29:1204-1213. 2020
  • Leveraging Genome and Phenome-Wide Association Studies to Investigate Genetic Risk of Acute Lymphoblastic Leukemia. 2020
  • Race May Not Impact Endocrine Therapy-Related Changes in Breast Density..  29:1049-1057. 2020
  • Environmental Quality and Invasive Breast Cancer. 2020
  • Relationships between the Nicotine Metabolite Ratio and a Panel of Exposure and Effect Biomarkers: Findings from Two Studies of U.S. Commercial Cigarette Smokers..  29:871-879. 2020
  • The Impact of Exclusive Use of Very Low Nicotine Cigarettes on Compensatory Smoking: An Inpatient Crossover Clinical Trial..  29:880-886. 2020
  • Racial Differences in Treatment and Survival among Veterans and Non-Veterans with Stage I NSCLC: An Evaluation of Veterans Affairs and SEER-Medicare Populations..  29:112-118. 2020
  • Incidence of Ductal Carcinoma In Situ in the United States, 2000-2014..  28:1316-1323. 2019
  • Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk..  28:1117-1126. 2019
  • Aspirin, NSAIDs, and Glioma Risk: Original Data from the Glioma International Case-Control Study and a Meta-analysis..  28:555-562. 2019
  • Validation of a Blood Biomarker for Identification of Individuals at High Risk for Gastric Cancer..  27:1472-1479. 2018
  • Antibody Responses to Streptococcus Gallolyticus Subspecies Gallolyticus Proteins in a Large Prospective Colorectal Cancer Cohort Consortium..  27:1186-1194. 2018
  • Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 (Alliance)..  27:1227-1230. 2018
  • Two HLA Class II Gene Variants Are Independently Associated with Pediatric Osteosarcoma Risk..  27:1151-1158. 2018
  • Common Genetic Variation and Susceptibility to Ovarian Cancer: Current Insights and Future Directions..  27:395-404. 2018
  • Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance)..  27:438-445. 2018
  • Helicobacter pylori Blood Biomarkers and Gastric Cancer Survival in China..  27:342-344. 2018
  • Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium..  27:174-182. 2018
  • Prediagnostic Smoking Is Associated with Binary and Quantitative Measures of ER Protein and ESR1 mRNA Expression in Breast Tumors..  27:67-74. 2018
  • History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium..  26:1470-1473. 2017
  • Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer-Response..  26:977. 2017
  • No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival..  26:420-424. 2017
  • Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci..  26:116-125. 2017
  • The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers..  26:126-135. 2017
  • Association between Body Powder Use and Ovarian Cancer: The African American Cancer Epidemiology Study (AACES)..  25:1411-1417. 2016
  • Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer..  25:1418-1425. 2016
  • Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium..  25:1114-1124. 2016
  • Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions..  25:1037-1042. 2016
  • Genetic Variation Associated with Longer Telomere Length Increases Risk of Chronic Lymphocytic Leukemia..  25:1043-1049. 2016
  • Assessing the Cumulative Contribution of New and Established Common Genetic Risk Factors to Early-Onset Prostate Cancer..  25:766-772. 2016
  • Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors..  25:780-790. 2016
  • Quality of Physician Communication about HPV Vaccine-Letter..  25:865. 2016
  • What Predicts an Advanced-Stage Diagnosis of Breast Cancer? Sorting Out the Influence of Method of Detection, Access to Care, and Biologic Factors..  25:613-623. 2016
  • Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer..  25:446-454. 2016
  • Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium..  25:470-478. 2016
  • Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study..  25:282-290. 2016
  • A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer..  25:193-200. 2016
  • Health care utilization, lifestyle, and emotional factors and mammography practices in the Childhood Cancer Survivor Study..  24:1699-1706. 2015
  • Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk..  24:1574-1584. 2015
  • The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies..  24:1366-1372. 2015
  • Functional Variants in Notch Pathway Genes NCOR2, NCSTN, and MAML2 Predict Survival of Patients with Cutaneous Melanoma..  24:1101-1110. 2015
  • Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci..  24:1121-1129. 2015
  • Population distribution of lifetime risk of ovarian cancer in the United States..  24:671-676. 2015
  • Survivors of childhood cancer in the United States: prevalence and burden of morbidity..  24:653-663. 2015
  • Symptoms, weight loss and physical function in a lifestyle intervention study of older cancer survivors..  24:763-764. 2015
  • Construction and analysis of the NCI-EDRN breast cancer reference set for circulating markers of disease..  24:435-441. 2015
  • Efficacy of a couple-based randomized controlled trial to help Latino fathers quit smoking during pregnancy and postpartum: the Parejas trial..  24:379-385. 2015
  • A peripheral circulating TH1 cytokine profile is inversely associated with prostate cancer risk in CLUE II..  23:2561-2567. 2014
  • Challenges and opportunities in international molecular cancer prevention research: An ASPO Molecular Epidemiology and the Environment and International Cancer Prevention Interest Groups Report..  23:2613-2617. 2014
  • Polymorphisms in MicroRNAs are associated with survival in non-small cell lung cancer..  23:2503-2511. 2014
  • Racial differences in adipose tissue distribution and risk of aggressive prostate cancer among men undergoing radiotherapy..  23:2404-2412. 2014
  • The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer..  23:2328-2337. 2014
  • Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease..  23:1997-2008. 2014
  • A review of the application of inflammatory biomarkers in epidemiologic cancer research..  23:1729-1751. 2014
  • Decline in physical activity level in the Childhood Cancer Survivor Study cohort..  23:1619-1627. 2014
  • A prospective study of plasma Selenoprotein P and lung cancer risk among low-income adults..  23:1238-1244. 2014
  • Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer..  23:1421-1427. 2014
  • Oral contraceptive use and risk of cancer--response..  23:677-678. 2014
  • Helicobacter pylori Biomarkers and Risk of Colorectal Oncogenesis--Response..  23:366. 2014
  • Association of marijuana smoking with oropharyngeal and oral tongue cancers: pooled analysis from the INHANCE consortium..  23:160-171. 2014
  • Helicobacter pylori protein-specific antibodies and risk of colorectal cancer..  22:1964-1974. 2013
  • Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review..  22:1931-1943. 2013
  • Molecular signatures of epithelial ovarian cancer: analysis of associations with tumor characteristics and epidemiologic risk factors..  22:1709-1721. 2013
  • Age-specific occurrence of HPV16- and HPV18-related cervical cancer..  22:1313-1318. 2013
  • Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome..  22:987-992. 2013
  • Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer..  22:880-890. 2013
  • Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression..  22:827-834. 2013
  • Transforming epidemiology for 21st century medicine and public health..  22:508-516. 2013
  • Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes..  22:461-466. 2013
  • Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans..  22:251-260. 2013
  • A variable age of onset segregation model for linkage analysis, with correction for ascertainment, applied to glioma..  21:2242-2251. 2012
  • Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men..  21:2185-2192. 2012
  • Mental and physical health-related quality of life among U.S. cancer survivors: population estimates from the 2010 National Health Interview Survey..  21:2108-2117. 2012
  • Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia..  21:1655-1663. 2012
  • Overexpression of protein phosphatase 4 correlates with poor prognosis in patients with stage II pancreatic ductal adenocarcinoma..  21:1336-1343. 2012
  • Cancer prevention and screening practices of siblings of childhood cancer survivors: a report from the Childhood Cancer Survivor Study..  21:1078-1088. 2012
  • Cigarette smoking and risk of meningioma: the effect of gender..  21:943-950. 2012
  • Prostate cancer risk in men with baseline history of coronary artery disease: results from the REDUCE Study..  21:576-581. 2012
  • Common variation in Nemo-like kinase is associated with risk of ovarian cancer..  21:523-528. 2012
  • Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes..  21:529-536. 2012
  • No association between Parkinson disease alleles and the risk of melanoma..  21:243-245. 2012
  • Telomere length and TERT functional polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck..  20:2642-2645. 2011
  • Methods to assess adverse health-related outcomes in cancer survivors..  20:2022-2034. 2011
  • Assessment of hepatocyte growth factor in ovarian cancer mortality..  20:1638-1648. 2011
  • MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium..  20:1793-1797. 2011
  • Plasma biomarker profiles differ depending on breast cancer subtype but RANTES is consistently increased..  20:1543-1551. 2011
  • Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk..  20:1131-1145. 2011
  • Body mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer..  20:779-792. 2011
  • Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer..  20:1028-1031. 2011
  • Race, African ancestry, and Helicobacter pylori infection in a low-income United States population..  20:826-834. 2011
  • A sex-specific association between a 15q25 variant and upper aerodigestive tract cancers..  20:658-664. 2011
  • Protein microarray analysis of mammary epithelial cells from obese and nonobese women at high risk for breast cancer: feasibility data..  20:476-482. 2011
  • Assessment of type of allergy and antihistamine use in the development of glioma..  20:370-378. 2011
  • Validation of genome-wide prostate cancer associations in men of African descent..  20:23-32. 2011
  • Detection of early-stage pancreatic adenocarcinoma..  19:2786-2794. 2010
  • Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium..  19:1822-1830. 2010
  • FAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck..  19:1484-1491. 2010
  • Urinary biomarkers of oxidative status in a clinical model of oxidative assault..  19:1506-1510. 2010
  • Genetic susceptibility variants for chronic lymphocytic leukemia..  19:1098-1102. 2010
  • Longitudinal predictors of nonadherence to maintenance of mammography..  19:1103-1111. 2010
  • Association between statins and prostate tumor inflammatory infiltrate in men undergoing radical prostatectomy..  19:722-728. 2010
  • Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium..  19:600-604. 2010
  • Cardiovascular risk factors in adult survivors of pediatric cancer--a report from the childhood cancer survivor study..  19:170-181. 2010
  • ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study..  19:245-250. 2010
  • Sexually transmitted infections and prostate cancer among men in the U.S. military..  18:2665-2671. 2009
  • Association of plasma micronutrient levels and urinary isoprostane with risk of lung cancer: the multiethnic cohort study..  18:1962-1970. 2009
  • Sam-pointed domain containing Ets transcription factor in luminal breast cancer pathogenesis..  18:1899-1903. 2009